Novel Gd-Loaded Silicon Nanohybrid: A Potential Epidermal Growth Factor Receptor Expressing Cancer Cell Targeting Magnetic Resonance Imaging Contrast Agent

Sougata Sinha, Wing Yin Tong, Nathan H. Williamson, Steven J.P. McInnes, Simon Puttick, Anna Cifuentes-Rius, Richa Bhardwaj, Sally E. Plush, Nicolas H. Voelcker

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Continuing our research efforts in developing mesoporous silicon nanoparticle-based biomaterials for cancer therapy, we employed here porous silicon nanoparticles as a nanocarrier to deliver contrast agents to diseased cells. Nanoconfinement of small molecule Gd-chelates (L1-Gd) enhanced the T1 contrast dramatically compared to distinct Gd-chelate (L1-Gd) by virtue of its slow tumbling rate, increased number of bound water molecules, and their occupancy time. The newly synthesized Gd-chelate (L1-Gd) was covalently grafted on silicon nanostructures and conjugated to an antibody specific for epidermal growth factor receptor (EGFR) via a hydrazone linkage. The salient feature of this nanosized contrast agent is the capability of EGFR targeted delivery to cancer cells. Mesoporous silicon nanoparticles were chosen as the nanocarrier because of their high porosity, high surface area, and excellent biodegradability. This type of nanosized contrast agent also performs well in high magnetic fields.

Original languageEnglish
Pages (from-to)42601-42611
Number of pages11
JournalACS Applied Materials and Interfaces
Volume9
Issue number49
DOIs
Publication statusPublished - 13 Dec 2017

Keywords

  • EGFR
  • Gd
  • MRI
  • porous silicon nanoparticles
  • T contrast agents

Cite this

@article{ee8b42bc6eca4c3194b6cb9a6f39aad1,
title = "Novel Gd-Loaded Silicon Nanohybrid: A Potential Epidermal Growth Factor Receptor Expressing Cancer Cell Targeting Magnetic Resonance Imaging Contrast Agent",
abstract = "Continuing our research efforts in developing mesoporous silicon nanoparticle-based biomaterials for cancer therapy, we employed here porous silicon nanoparticles as a nanocarrier to deliver contrast agents to diseased cells. Nanoconfinement of small molecule Gd-chelates (L1-Gd) enhanced the T1 contrast dramatically compared to distinct Gd-chelate (L1-Gd) by virtue of its slow tumbling rate, increased number of bound water molecules, and their occupancy time. The newly synthesized Gd-chelate (L1-Gd) was covalently grafted on silicon nanostructures and conjugated to an antibody specific for epidermal growth factor receptor (EGFR) via a hydrazone linkage. The salient feature of this nanosized contrast agent is the capability of EGFR targeted delivery to cancer cells. Mesoporous silicon nanoparticles were chosen as the nanocarrier because of their high porosity, high surface area, and excellent biodegradability. This type of nanosized contrast agent also performs well in high magnetic fields.",
keywords = "EGFR, Gd, MRI, porous silicon nanoparticles, T contrast agents",
author = "Sougata Sinha and Tong, {Wing Yin} and Williamson, {Nathan H.} and McInnes, {Steven J.P.} and Simon Puttick and Anna Cifuentes-Rius and Richa Bhardwaj and Plush, {Sally E.} and Voelcker, {Nicolas H.}",
year = "2017",
month = "12",
day = "13",
doi = "10.1021/acsami.7b14538",
language = "English",
volume = "9",
pages = "42601--42611",
journal = "ACS Applied Materials and Interfaces",
issn = "1944-8244",
publisher = "ACS Publications",
number = "49",

}

Novel Gd-Loaded Silicon Nanohybrid : A Potential Epidermal Growth Factor Receptor Expressing Cancer Cell Targeting Magnetic Resonance Imaging Contrast Agent. / Sinha, Sougata; Tong, Wing Yin; Williamson, Nathan H.; McInnes, Steven J.P.; Puttick, Simon; Cifuentes-Rius, Anna; Bhardwaj, Richa; Plush, Sally E.; Voelcker, Nicolas H.

In: ACS Applied Materials and Interfaces, Vol. 9, No. 49, 13.12.2017, p. 42601-42611.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Novel Gd-Loaded Silicon Nanohybrid

T2 - A Potential Epidermal Growth Factor Receptor Expressing Cancer Cell Targeting Magnetic Resonance Imaging Contrast Agent

AU - Sinha, Sougata

AU - Tong, Wing Yin

AU - Williamson, Nathan H.

AU - McInnes, Steven J.P.

AU - Puttick, Simon

AU - Cifuentes-Rius, Anna

AU - Bhardwaj, Richa

AU - Plush, Sally E.

AU - Voelcker, Nicolas H.

PY - 2017/12/13

Y1 - 2017/12/13

N2 - Continuing our research efforts in developing mesoporous silicon nanoparticle-based biomaterials for cancer therapy, we employed here porous silicon nanoparticles as a nanocarrier to deliver contrast agents to diseased cells. Nanoconfinement of small molecule Gd-chelates (L1-Gd) enhanced the T1 contrast dramatically compared to distinct Gd-chelate (L1-Gd) by virtue of its slow tumbling rate, increased number of bound water molecules, and their occupancy time. The newly synthesized Gd-chelate (L1-Gd) was covalently grafted on silicon nanostructures and conjugated to an antibody specific for epidermal growth factor receptor (EGFR) via a hydrazone linkage. The salient feature of this nanosized contrast agent is the capability of EGFR targeted delivery to cancer cells. Mesoporous silicon nanoparticles were chosen as the nanocarrier because of their high porosity, high surface area, and excellent biodegradability. This type of nanosized contrast agent also performs well in high magnetic fields.

AB - Continuing our research efforts in developing mesoporous silicon nanoparticle-based biomaterials for cancer therapy, we employed here porous silicon nanoparticles as a nanocarrier to deliver contrast agents to diseased cells. Nanoconfinement of small molecule Gd-chelates (L1-Gd) enhanced the T1 contrast dramatically compared to distinct Gd-chelate (L1-Gd) by virtue of its slow tumbling rate, increased number of bound water molecules, and their occupancy time. The newly synthesized Gd-chelate (L1-Gd) was covalently grafted on silicon nanostructures and conjugated to an antibody specific for epidermal growth factor receptor (EGFR) via a hydrazone linkage. The salient feature of this nanosized contrast agent is the capability of EGFR targeted delivery to cancer cells. Mesoporous silicon nanoparticles were chosen as the nanocarrier because of their high porosity, high surface area, and excellent biodegradability. This type of nanosized contrast agent also performs well in high magnetic fields.

KW - EGFR

KW - Gd

KW - MRI

KW - porous silicon nanoparticles

KW - T contrast agents

UR - http://www.scopus.com/inward/record.url?scp=85038215756&partnerID=8YFLogxK

U2 - 10.1021/acsami.7b14538

DO - 10.1021/acsami.7b14538

M3 - Article

VL - 9

SP - 42601

EP - 42611

JO - ACS Applied Materials and Interfaces

JF - ACS Applied Materials and Interfaces

SN - 1944-8244

IS - 49

ER -